
|Videos|August 4, 2017
What Do Specialty Pharmacists Need to Understand About Cancer Care?
With a shift from intravenous to self-administered medication, specialty pharmacists are key in patient education.
Advertisement
Brandon Shank, PharmD, MPH, BCOP, Clinical Pharmacy Specialist, explains why specialty pharmacists must understand the logitistics, toxicities, and the reimbursement payment models of the new, self-administered treatments for cancer. It is important that specialty pharmacists understand these treatments in order to provide proper patient education.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
States Push Forward on Insurance Mandates for GLP-1 and Obesity Treatments
2
FDA Expands Approval of Sotatercept-Csrk for Pulmonary Arterial Hypertension
3
First FDA-Approved Oral Liquid Sitagliptin for Adults with Type 2 Diabetes
4
Oxaliplatin as Part of Sequential Chemotherapy Shows Promise in Metastatic Pancreatic Cancer
5













































































































































































































